Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bay 50-4798 in HIV patients on HAART
NCT00059462Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2002
- Primary completion
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of BAY 50-4798 in human immunodeficiency virus infection (HIV), sponsored by Bayer. Started Dec 2002; status: completed.
02
Drugs
BAY 50-4798
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00059462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059462.